VISIONEERING TECHNOLOGIES, INC. Visioneering Technologies, Inc.
Equities
VTI
AU000000VTI2
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.12 AUD | 0.00% |
|
+20.00% | -52.00% |
| Apr. 24 | Transcript : Visioneering Technologies, Inc., Q1 2024 Earnings Call, Apr 23, 2024 | |
| Feb. 28 | Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presenter SpeechDavid Mazzo (Executives)Good morning, and good evening to all of you. My name ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Visioneering Technologies, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture, sale and distribution of a contact lens, the NaturalVue Multifocal 1 Day (NaturalVue MF) contact lens. The Company operates through two segments: North America and Europe / Asia-Pacific. The North America segment includes its operations in the United States and Canada. The Europe/Asia-Pacific segment includes its operations outside of North America. Its flagship product is the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens for adults with Presbyopia and children with Myopia. The Company sells its contact lenses in the United States, Europe, Australia, New Zealand, Hong Kong, Singapore, Canada and Malaysia. The Company manages the warehousing and distribution of its products through a contract with a third-party logistics provider (the 3PL).
Calendar
2024-07-15
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -52.00% | 4.42M | |
| +22.00% | 44.19B | |
| +2.85% | 19.46B | |
| -16.08% | 2.31B | |
| +17.23% | 1.92B | |
| +27.36% | 1.23B | |
| -34.93% | 755M | |
| -40.97% | 699M | |
| -6.32% | 677M | |
| +28.48% | 510M |
- Stock Market
- Equities
- VTI Stock
- News Visioneering Technologies, Inc.
- Transcript : Visioneering Technologies, Inc. - Shareholder/Analyst Call
